Literature DB >> 119266

Desmethylimipramine (DMI) counteracts learned helplessness in rats.

A I Leshner, H Remler, A Biegon, D Samuel.   

Abstract

In a study of the mechanisms controlling the learned helplessness phenomenon, rats were exposed to either inescapable preshocks or control procedures, treated with one of three dosages of desmethylimipramine, and tested for later adaptive responding. This catecholamine modulator attenuated the deficits in escape responding that ordinarily follow prior exposure to inescapable preshocks, and it did so in a dose-dependent fashion. These findings support the position that the learned helplessness phenomenon is mediated by catecholamine changes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 119266     DOI: 10.1007/bf00427633

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance.

Authors:  H Anisman; G Remington; L S Sklar
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

2.  Cognitive processes and models of depression.

Authors:  L R Huesmann
Journal:  J Abnorm Psychol       Date:  1978-02

3.  Intraventricular injection of antivasopressin serum blocks learned helplessness in rats.

Authors:  A I Leshner; R Hofstein; D Samuel; T B van Wimersma Greidanus
Journal:  Pharmacol Biochem Behav       Date:  1978-12       Impact factor: 3.533

  3 in total
  11 in total

Review 1.  Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.

Authors:  John Dunlop; Karen L Marquis; H K Lim; Louis Leung; John Kao; Cynthia Cheesman; Sharon Rosenzweig-Lipson
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Richard L. Solomon and learned helplessness.

Authors:  J B Overmier
Journal:  Integr Physiol Behav Sci       Date:  1996 Oct-Dec

3.  Behaviour of a genetic mouse model of depression in the learned helplessness paradigm.

Authors:  Laure Bougarel; Jérôme Guitton; Luc Zimmer; Jean-Marie Vaugeois; Malika El Yacoubi
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

4.  The reversal effect of antidepressants on the escape deficit induced by inescapable shock in rats.

Authors:  H Kametani; S Nomura; J Shimizu
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 5.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Effect of imipramine in the "learned helplessness" model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine.

Authors:  M Geoffroy; J Scheel-Krüger; A V Christensen
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.

Authors:  Abbey L Reed; Jeffrey C Anderson; David B Bylund; Frederick Petty; Hesham El Refaey; H Kevin Happe
Journal:  Psychopharmacology (Berl)       Date:  2009-04-22       Impact factor: 4.530

8.  Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.

Authors:  P Skolnick; R Miller; A Young; K Boje; R Trullas
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice.

Authors:  B J Caldarone; K Karthigeyan; A Harrist; J G Hunsberger; E Wittmack; S L King; P Jatlow; M R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2003-07-15       Impact factor: 4.530

Review 10.  kappa-Opioid receptor signaling and brain reward function.

Authors:  Adrie W Bruijnzeel
Journal:  Brain Res Rev       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.